BSE Live
Oct 24, 16:01Prev. Close
922.35
Open Price
925.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 24, 15:46Prev. Close
921.15
Open Price
926.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Alivus Life Sciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 2,339.84 | 2,184.77 | 2,047.84 | 2,087.45 | 1,861.40 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 2,339.84 | 2,184.77 | 2,047.84 | 2,087.45 | 1,861.40 | |
| Total Operating Revenues | 2,386.88 | 2,283.21 | 2,161.22 | 2,123.21 | 1,885.17 | |
| Other Income | 34.57 | 12.04 | 28.96 | 14.70 | 0.81 | |
| Total Revenue | 2,421.45 | 2,295.26 | 2,190.18 | 2,137.92 | 1,885.98 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 1,053.50 | 1,058.58 | 1,098.53 | 1,001.56 | 976.20 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 2.43 | 3.17 | 2.48 | 2.66 | 1.82 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 27.35 | -56.57 | -84.44 | 41.32 | -70.70 | |
| Employee Benefit Expenses | 251.70 | 258.16 | 180.18 | 168.72 | 149.13 | |
| Finance Costs | 2.41 | 1.55 | 0.55 | 27.96 | 87.55 | |
| Depreciation And Amortisation Expenses | 60.61 | 53.45 | 42.09 | 37.88 | 33.39 | |
| Other Expenses | 369.32 | 345.63 | 322.18 | 292.89 | 237.65 | |
| Total Expenses | 1,767.32 | 1,663.97 | 1,561.57 | 1,572.99 | 1,415.03 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 654.13 | 631.29 | 628.61 | 564.93 | 470.94 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 654.13 | 631.29 | 628.61 | 564.93 | 470.94 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 162.44 | 152.21 | 150.61 | 137.63 | 112.75 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 6.06 | 8.19 | 11.04 | 8.57 | 6.62 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 168.50 | 160.40 | 161.65 | 146.20 | 119.36 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 485.63 | 470.89 | 466.96 | 418.72 | 351.58 | |
| Profit/Loss From Continuing Operations | 485.63 | 470.89 | 466.96 | 418.72 | 351.58 | |
| Profit/Loss For The Period | 485.63 | 470.89 | 466.96 | 418.72 | 351.58 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 39.63 | 38.43 | 38.11 | 35.63 | 32.61 | |
| Diluted EPS (Rs.) | 39.53 | 38.38 | 38.11 | 35.63 | 32.61 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 275.69 | 385.96 | 128.65 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 250.00 | 1,125.00 | 1,050.00 | 1,050.00 | 0.00 |
05.08.2025
Alivus Life Standalone June 2025 Net Sales at Rs 601.85 crore, up 2.25% Y-o-Y
25.10.2024
Glenmark Life Standalone September 2024 Net Sales at Rs 506.88 crore, down 14.86% Y-o-Y
26.07.2024
Glenmark Life Standalone June 2024 Net Sales at Rs 588.62 crore, up 1.76% Y-o-Y
26.04.2024
Glenmark Life Standalone March 2024 Net Sales at Rs 536.60 crore, down 13.64% Y-o-Y